1-4 of 4
Lawrence Fong
Close
Sort by
Journal Articles

Pharmacodynamic Analysis of CAR-T Cell Persistence in Patients with Hematologic Malignancies Treated with NKTR-255, an IL-15 Receptor Agonist That Enhances CD8 + T-Cells: Preliminary Results from a Phase 1 Study

Cameron J. Turtle, Elizabeth Budde, Krina K. Patel, Miguel-Angel Perales, Andrew J. Cowan, Hayder Saeed, Julio C. Chavez, Alexandre V. Hirayama, Delaney R. Kirchmeier, Murali Janakiram, Kai Wu, Lawrence Fong, Zachary Lee, Neha Dixit, Xiaoli Wang, Kazuharu Kai, Mario Q. Marcondes, Jonathan Zalevsky, Nina Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 2815.
https://doi.org/10.1182/blood-2021-147350
Published: 2021
Journal Articles

CTLA4 blockade expands FoxP3 + regulatory and activated effector CD4 + T cells in a dose-dependent fashion

Brian Kavanagh, Shaun O'Brien, David Lee, Yafei Hou, Vivian Weinberg, Brian Rini, James P. Allison, Eric J. Small, Lawrence Fong
Journal: Blood
Blood (2008) 112 (4): 1175–1183.
https://doi.org/10.1182/blood-2007-11-125435
Published: 2008
Journal Articles

In vivo manipulation of dendritic cells to induce therapeutic immunity

Miriam Merad, Tomoharu Sugie, Edgar G. Engleman, Lawrence Fong
Journal: Blood
Blood (2002) 99 (5): 1676–1682.
https://doi.org/10.1182/blood.V99.5.1676
Published: 2002
Journal Articles

Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo

Miriam Merad, Lawrence Fong, Jakob Bogenberger, Edgar G. Engleman
Journal: Blood
Blood (2000) 96 (5): 1865–1872.
https://doi.org/10.1182/blood.V96.5.1865
Published: 2000